These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8781689)

  • 21. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A structured patient identification model for medication therapy management services in a community pharmacy.
    Pagano GM; Groves BK; Kuhn CH; Porter K; Mehta BH
    J Am Pharm Assoc (2003); 2017; 57(5):619-623.e1. PubMed ID: 28733156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of medication use and pharmacy services for visually impaired persons: Perspectives from both visually impaired and community pharmacists.
    Lee BH; Lee YJ
    Disabil Health J; 2019 Jan; 12(1):79-86. PubMed ID: 30170955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations.
    Newman TV; Hernandez I; Keyser D; San-Juan-Rodriguez A; Swart ECS; Shrank WH; Parekh N
    J Manag Care Spec Pharm; 2019 Sep; 25(9):995-1000. PubMed ID: 31456493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A developmental evaluation of an intraprofessional Pharmacy Communication Partnership (PROMPT) to improve transitions in care from hospital to community: A mixed-methods study.
    Guilcher SJT; Fernandes O; Luke MJ; Wong G; Lui P; Cameron K; Pariser P; Raco V; Kak K; Varghese S; Papastergiou J; McCarthy LM
    BMC Health Serv Res; 2020 Feb; 20(1):99. PubMed ID: 32041591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a training and communication-network nephrology program for community pharmacists.
    Lalonde L; Normandeau M; Lamarre D; Lord A; Berbiche D; Corneille L; Prud'homme L; Laliberté MC
    Pharm World Sci; 2008 Dec; 30(6):924-33. PubMed ID: 18802782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
    Nkansah N; Mostovetsky O; Yu C; Chheng T; Beney J; Bond CM; Bero L
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000336. PubMed ID: 20614422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: role of the community pharmacist.
    Foubert K; Mehuys E; Claes L; Van Den Abeele D; Haems M; Somers A; Petrovic M; Boussery K
    Acta Clin Belg; 2019 Oct; 74(5):326-333. PubMed ID: 30235081
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementation of a community pharmacy-based influenza vaccination program.
    Ernst ME; Chalstrom CV; Currie JD; Sorofman B
    J Am Pharm Assoc (Wash); 1997; NS37(5):570-80. PubMed ID: 9479410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supporting patients with mental illness: Deconstructing barriers to community pharmacist access.
    Calogero S; Caley CF
    J Am Pharm Assoc (2003); 2017; 57(2):248-255. PubMed ID: 28153705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
    Hatah E; Braund R; Duffull SB; Tordoff J
    J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.